Another research showed that bevacizumab, a standard chemo drug in glioblastoma treatment could increase the chemotherapy resistance of glioblastoma cells by elevating their autophagy levels, achieved through the suppression of the Akt-mTOR signaling pathway. The gene discussed is AKT1; the disease is glioblastoma.